British Journal of Cardiac Nursing - Trial Subscriptions

  Get your first 3 issues for only £3!
British Journal of Cardiac Nursing
 delivers authoritative and accessible professional content to keep you ahead of developments in this demanding specialism. It prioritises reader's lifelong learning, and is dedicated to the provision of the best posssible care. It covers all cardiovascular conditions, and all articles are peer-reviewed by leading figures in practice and academia to ensure both quality and relevance.

What's included?

Why subscribe?

Every issue contains evidence-based clinical reviews, important original research findings and specialist education, with advice on the key professional issues that affect nurses.

- Stay up-to-date with best practice
- Develop advanced clinical skills
- Fulfil your required CPD activity
- Deliver person-centred care

A subscription also includes unlimited access to CPD Launchpad - the reflective online platform helping nurses to revalidate. 

Trial subscription offer

Subscribe now and get your first 3 issues for only £3 - a saving of over 92% on our normal rate. Try Companion Animal today and discover how we can help you in practice. We are sure you won't be disappointed - but you can cancel your subscription anytime.

*£3 for the first three issues of your subscription. Price will revert to standard rate of £42.00 per quarter thereafter. Payment taken by Direct Debit every three months.

British Journal of Cardiac Nursing Print £3 for 3 issues

SAVE 92%

Latest print issues

CPD Launchpad

From £3.00

British Journal of Cardiac Nursing Website £3 for 3 months

SAVE 92%

Digital archive access

CPD Launchpad

From £3.00

Money-back guarantee. If – for whatever reason – you are not happy with the first issue you receive, our 30 day money-back guarantee means we will offer you a full refund, so you have nothing to lose. The first issue will be yours to keep.

Institutional subscriptions. Click here for information regarding our institutional rates for universities and private or public companies.